The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Human Macrophage Responses to Clinical Isolates from the Mycobacterium tuberculosis Complex Discriminate between Ancient and Modern Lineages
Open accessAbstract
The aim of the present study was to determine whether there is a correlation between phylogenetic relationship and inflammatory response amongst a panel of clinical isolates representative of the global diversity of the human Mycobacterium tuberculosis Complex (MTBC). Measurement of cytokines from infected human peripheral blood monocyte-derived macrophages revealed a wide variation in the response to different strains. The same pattern of high or low response to individual strains was observed for different pro-inflammatory cytokines and chemokines, and was conserved across multiple human donors. Although each major phylogenetic lineage of MTBC included strains inducing a range of cytokine responses, we found that overall inflammatory phenotypes differed significantly across lineages. In particular, comparison of evolutionarily modern lineages demonstrated a significant skewing towards lower early inflammatory response. The differential response to ancient and modern lineages observed using GM-CSF derived macrophages was also observed in autologous monocyte-derived dendritic cells and murine bone marrow-derived macrophages, but not in human unfractionated peripheral blood mononuclear cells. We hypothesize that the reduced immune responses to modern lineages contribute to more rapid disease progression and transmission, which might be a selective advantage in the context of expanding human populations. In addition to the lineage effects, the large strain-to-strain variation in innate immune responses elicited by MTBC will need to be considered in tuberculosis vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
The regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
A new evolutionary scenario for the Mycobacterium tuberculosis complex
Brosch, R., Gordon, S. V., Marmiesse, M., Brodin, P., Buchrieser, C., Eiglmeier, K., Garnier, T., Gutierrez, C., Hewinson, G., Kremer, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052548299 · Cited by 1,603
Verreck, F. A. W., de Boer, T., Langenberg, D. M. L., Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Waal-Malefyt, R., & Ottenhoff, T. H. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400983101 · Cited by 977
Variable host–pathogen compatibility in Mycobacterium tuberculosis
Gagneux, S., DeRiemer, K., Van, T., Kato-Maeda, M., de Jong, B. C., Narayanan, S., Nicol, M., Niemann, S., Kremer, K., Gutierrez, M. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511240103 · Cited by 971
Self-citationDirect recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle
Ishikawa, E., Ishikawa, T., Morita, Y. S., Toyonaga, K., Yamada, H., Takeuchi, O., Kinoshita, T., Akira, S., Yoshikai, Y., & Yamasaki, S. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091750 · Cited by 792
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Reed, M. B., Domenech, P., Manca, C., Su, H., Barczak, A. K., Kreiswirth, B. N., Kaplan, G., & Barry, C. E. (2004) · Nature · doi:10.1038/nature02837 · Cited by 762
Gagneux, S., & Small, P. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70108-1 · Cited by 712
Self-citationHuman T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
Comas, I., Chakravartti, J., Small, P. M., Galagan, J., Niemann, S., Kremer, K., Ernst, J. D., & Gagneux, S. (2010) · Nature Genetics · doi:10.1038/ng.590 · Cited by 707
Self-citationHigh Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human Demography
Hershberg, R., Lipatov, M., Small, P. M., Sheffer, H., Niemann, S., Homolka, S., Roach, J. C., Kremer, K., Petrov, D. A., Feldman, M. W., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060311 · Cited by 593
Self-citationCaws, M., Thwaites, G., Dunstan, S., Hawn, T. R., Thi Ngoc Lan, N., Thuong, N. T. T., Stepniewska, K., Huyen, M. N. T., Bang, N. D., Huu Loc, T., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000034 · Cited by 498
Self-citationLÓPEZ, B., AGUILAR, D., OROZCO, H., BURGER, M., ESPITIA, C., RITACCO, V, BARRERA, L., KREMER, K., HERNANDEZ-PANDO, R., HUYGEN, K., et al. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02171.x · Cited by 449
Mycobacterium africanum—Review of an Important Cause of Human Tuberculosis in West Africa
de Jong, B. C., Antonio, M., & Gagneux, S. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000744 · Cited by 312
Self-citationde Jong, B. C., Hill, P. C., Aiken, A., Awine, T., Antonio, M., Adetifa, I. M., Jackson‐Sillah, D. J., Fox, A., DeRiemer, K., Gagneux, S., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/591504 · Cited by 289
Self-citationRao, V., Fujiwara, N., Porcelli, S. A., & Glickman, M. S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041668 · Cited by 238
The equilibria that allow bacterial persistence in human hosts
Blaser, M. J., & Kirschner, D. (2007) · Nature · doi:10.1038/nature06198 · Cited by 236
Myths and misconceptions: the origin and evolution of Mycobacterium tuberculosis
Smith, N. H., Hewinson, R. G., Kremer, K., Brosch, R., & Gordon, S. V. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2165 · Cited by 229
Differential Monocyte Activation Underlies Strain-Specific Mycobacterium tuberculosis Pathogenesis
Manca, C., Reed, M. B., Freeman, S., Mathema, B., Kreiswirth, B., Barry, C. E., & Kaplan, G. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5511-5514.2004 · Cited by 221
Hanekom, M., van der Spuy, G. D., Streicher, E., Ndabambi, S. L., McEvoy, C. R. E., Kidd, M., Beyers, N., Victor, T. C., van Helden, P. D., & Warren, R. M. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02191-06 · Cited by 210
Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs
Jo, E.-K. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f88b5d · Cited by 182
Does M. tuberculosis genomic diversity explain disease diversity?
Coscolla, M., & Gagneux, S. (2010) · Drug Discovery Today: Disease Mechanisms · doi:10.1016/j.ddmec.2010.09.004 · Cited by 163
Self-citationKeating, L. A., Wheeler, P. R., Mansoor, H., Inwald, J. K., Dale, J., Hewinson, R. G., & Gordon, S. V. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04524.x · Cited by 151
The clinical consequences of strain diversity in Mycobacterium tuberculosis
Nicol, M. P., & Wilkinson, R. J. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.03.025 · Cited by 145
Sinsimer, D., Huet, G., Manca, C., Tsenova, L., Koo, M.-S., Kurepina, N. E., Kana, B. D., Mathema, B., Marras, S. A. E., Kreiswirth, B. N., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01663-07 · Cited by 139
Kong, Y., Cave, M. D., Zhang, L., Foxman, B., Marrs, C. F., Bates, J. H., & Yang, Z. H. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01459-06 · Cited by 130
Newton, S. M., Smith, R. J., Wilkinson, K. A., Nicol, M. P., Garton, N. J., Staples, K. J., Stewart, G. R., Wain, J. R., Martineau, A. R., Fandrich, S. E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604283103 · Cited by 109
N’Diaye, E.-N., Darzacq, X., Astarie‐Dequeker, C., Daffé, M., Calafat, J., & Maridonneau‐Parini, I. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4983 · Cited by 87
Mannan Chain Length Controls Lipoglycans Signaling via and Binding to TLR2
Nigou, J., Vasselon, T., Ray, A. A., Constant, P., Gilleron, M., Besra, G. S., Sutcliffe, I. C., Tiraby, G., & Puzo, G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6696 · Cited by 81
Marquina‐Castillo, B., García‐García, L., Ponce‐de‐León, A., Jiménez-Corona, M. E., Bobadilla-del-Valle, M., Cano‐Arellano, B., Canizales‐Quintero, S., Martínez‐Gamboa, A., Kato‐Maeda, M., Robertson, B. D., et al. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.03004.x · Cited by 74
Self-citationRakotosamimanana, N., Raharimanga, V., Andriamandimby, S. F., Soares, J.-L., Doherty, T. M., Ratsitorahina, M., Ramarokoto, H., Zumla, A. I., Huggett, J. F., Rook, G. A. W., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00049-10 · Cited by 51
Stewart, G. R., Wilkinson, K. A., Newton, S. M., Sullivan, S. M., Neyrolles, O., Wain, J. R., Patel, J., Pool, K.-L., Young, D. B., & Wilkinson, R. J. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6831-6837.2005 · Cited by 42
Self-citation
Cited by
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Tuberculosis and HIV Co-Infection
Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E., & Källenius, G. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002464 · Cited by 764
Dheda, K., Barry, C. E., & Maartens, G. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00151-8 · Cited by 599
Drain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Ford, C. B., Shah, R. R., Maeda, M. K., Gagneux, S., Murray, M. B., Cohen, T., Johnston, J. C., Gardy, J., Lipsitch, M., & Fortune, S. M. (2013) · Nature Genetics · doi:10.1038/ng.2656 · Cited by 457
Self-citation
Metadata
- Authors
- Portevin, D., Gagneux, S., Comas, I., & Young, D.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-03-03
- Volume
- 7
- Issue
- 3
- Pages
- e1001307
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2072680575
- Cited by
- 277
- References
- 31
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.